Pharmaceutical - Pharmaceutical, Global

Filter

Current filters:

PharmaceuticalGlobal

Popular Filters

1 to 25 of 290 results

EXPERT VIEW: Pfizer and AstraZeneca, a marriage not to be – yet?

EXPERT VIEW: Pfizer and AstraZeneca, a marriage not to be – yet?

19-08-2014

Mergers and acquisitions may excite the markets and shareholders on both sides but their record of success…

GlobalInterviewsMergers & AcquisitionsPharmaceutical

Patently Unfair? Two views on the IP vs Competition law debate

Patently Unfair? Two views on the IP vs Competition law debate

19-08-2014

Intellectual Property (IP) and competition law are generally considered distinct specialisms. One involves…

European CommissionGeneric manufacturerGeneric productGlobalIntellectual property lawPatentsPharmaceuticalSpecialist competition lawyer

China’s ZAI Lab in-licenses two respiratory drugs from Sanofi

China’s ZAI Lab in-licenses two respiratory drugs from Sanofi

14-08-2014

China-based ZAI Lab has obtained global rights for two novel compounds from French pharma major Sanofi,…

Chronic lower respiratory diseasesGlobalLicensingPharmaceuticalRespiratory and PulmonarySanofiZAI Lab

Allergan acquires LiRIS program from TARIS Biomedical

Allergan acquires LiRIS program from TARIS Biomedical

14-08-2014

US drugmaker Allergan has closed a transaction to acquire worldwide rights to privately-held TARIS Biomedical’s…

AllerganGenito-urinaryGlobalLicensingLiRISPharmaceuticalTARIS Biomedical

New treatments will partially compensate for unipolar depression drugs coming out of patent

New treatments will partially compensate for unipolar depression drugs coming out of patent

14-08-2014

New antidepressants and antipsychotics will offset a steep decline in sales following genericization…

Antidepressant therapiesDecision Resources GroupGlobalMarkets & MarketingNeurologicalPharmaceuticalPsychiatryUnipolar depression

$260.2 billion-worth of deals in the global PMB industry in first-half 2014

$260.2 billion-worth of deals in the global PMB industry in first-half 2014

12-08-2014

Global pharma, medical and biotechnology (PMB) M&A activity during the first half of 2014 hit the highest…

Business FinanceGlobalMergers & AcquisitionsPharmaceutical

Sanofi in $925 million deal to commercialize MannKind’s Afrezza

Sanofi in $925 million deal to commercialize MannKind’s Afrezza

11-08-2014

French pharma major Sanofi has entered into a worldwide exclusive licensing agreement with the USA’s…

AfrezzaDiabetesGlobalInsulin therapyLicensingMannKindPeptide hormonesPharmaceuticalSanofi

Existing diabetes drug Victoza could be effective treatment for world’s obese

Existing diabetes drug Victoza could be effective treatment for world’s obese

06-08-2014

Pharmaceutical companies are racing to find a new form of obesity drug as patient numbers spiral and…

Anti-diabetic drugsDiabetesGastro-intestinalsGlobalMarkets & MarketingNovo NordiskPeptide hormonesPharmaceuticalVictoza

EXPERT VIEW: How can pharmaceutical companies adapt to the digital era?

EXPERT VIEW: How can pharmaceutical companies adapt to the digital era?

06-08-2014

‘Digital pharma’ is by no means a new concept for pharmaceutical marketers. But what is new is that…

FinancialGlobalMarkets & MarketingPharmaceutical

Medivir licenses RSV program from Boehringer Ingelheim

Medivir licenses RSV program from Boehringer Ingelheim

05-08-2014

Swedish drugmaker Medivir has entered a license agreement with German family-owned pharma major Boehringer…

Boehringer IngelheimGlobalHuman respiratory syncytial virusLicensingMedivirMononegaviralesPharmaceuticalRespiratory and PulmonaryViral diseases

Private equity firms could be looking to acquire mature GSK and Sanofi brands

Private equity firms could be looking to acquire mature GSK and Sanofi brands

05-08-2014

Private equity groups KKR and Warburg Pincus are considering a $10 billion plan to buy drug brands from…

Business FinanceFinancialGlaxoSmithKlineGlobalMylanPharmaceuticalSanofi

Ziopharm and Solasia amend collaboration for darinaparsin

Ziopharm and Solasia amend collaboration for darinaparsin

01-08-2014

US drug developer Ziopharm Oncology and Japan’s Solasia Pharma, a developer of oncology pharmaceuticals…

darinaparsinGlobalLicensingOncologyPharmaceuticalSolasia PharmaZinaparZiopharm Oncology

Albumin sales to play major part in growth of billion-dollar critical care market

Albumin sales to play major part in growth of billion-dollar critical care market

31-07-2014

The critical care market across eight major countries will grow to $2.5 billion by 2020, according to…

AlbuminBlood proteinsGlobalMarkets & MarketingPharmaceutical

Global insulin market set to reach $32.24 billion in 2019

Global insulin market set to reach $32.24 billion in 2019

28-07-2014

The global insulin market was valued at $19.99 billion in 2012 and is expected to expand at a compound…

AfrezzaChinaDiabetesEli LillyGlobalInsulinLY2605541MannKindMarkets & MarketingMerck & CoMK-1293NN1218Novo NordiskPharmaceutical

Medical community in shock after loss of AIDS experts and WHO employee in MH17 plane crash

Medical community in shock after loss of AIDS experts and WHO employee in MH17 plane crash

18-07-2014

The medical community is in shock after it emerged that dozens of delegates headed to the 20th International…

GlobalHealthHIV/AIDSInternational AIDS SocietyInternational AIDS SocietyPharmaceuticalUkraine

Trametinib and dabrafenib gives overall survival benefit compared to vemurafenib

Trametinib and dabrafenib gives overall survival benefit compared to vemurafenib

17-07-2014

GlaxoSmithKline says that the Independent Data Monitoring Committee (IDMC) has recommended a Phase III…

BRAFdabrafenibGlobalGSKMetastatic cutaneous melanomaOncologyPharmaceuticalResearchtrametinibvemurafenib

LEO Pharma strikes global dermatology deal with KLOK Tech

LEO Pharma strikes global dermatology deal with KLOK Tech

16-07-2014

Danish dermatology specialist LEO Pharma and Canada’s KLOX Technologies, both privately-held companies,…

Acne vulgarisDermatologicalsGlobalKLOX TechnologiesLEO PharmaLicensingPharmaceutical

inVentiv and ACRES partner to create a global research platform for clinical trials

inVentiv and ACRES partner to create a global research platform for clinical trials

11-07-2014

Two bodies are partnering to fast-track the development of a global system to support responsible conduct…

BiotechnologyClinical researchDrug developmentGlobalGreg KoskiinVentive HealthPharmaceuticalResearch

Report: Why pharmaceutical prices drop once drugs are off-patent

Report: Why pharmaceutical prices drop once drugs are off-patent

07-07-2014

The USA-based Pacific Research Institute has released a new report, titled The Economics of Pharmaceutical…

GlobalPatentsPharmaceuticalPricing

Incremental innovations in pharma industry spawn life-saving improvements, says think-tank

27-06-2014

Despite claims from critics, incremental innovations by pharmaceutical companies provide great value…

GlobalHealthcarePharmaceuticalResearch

1 to 25 of 290 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top